LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Please provide your email address to receive an email when new articles are posted on . Odds for survival on ECMO to transplant went down if the patient had an older age at listing. Survival did not ...
Breathing. That critical inhale/exhale operation of the lungs is something we often take for granted — until something goes wrong and respiratory problems result. The Center for Acute Respiratory ...
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
Please provide your email address to receive an email when new articles are posted on . Among patients receiving extracorporeal membrane oxygenation, the presence of obesity did not impact mortality ...
San Antonio, Texas – June 3, 2024 – Recognizing an unusual prevalence of bloodstream infections (BSI) that threatened extremely ill patients receiving Extracorporeal Membrane Oxygenation, or ECMO, ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results